Medtronic, Inc. (MDT) Tops Q2 EPS by 2c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $92.13 -0.69%
EPS Growth %: -2.2%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -2.2%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q2 EPS of $0.84, $0.02 better than the analyst estimate of $0.82. Revenue for the quarter came in at $4.13 billion versus the consensus estimate of $4.07 billion.
Medtronic, Inc. reaffirmed FY2011 guidance.
Medtronic, Inc. reaffirmed FY2011 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Reiterates Buy Rating on Medtronic, Inc. (MDT)
- Citi Cfo: Expecting To Top Full-year 11% Rotce Guidance
- Nucor projects Q3 2026 earnings above prior year, below estimates
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
